Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.2137 per EA under NDC 13107021205. Its NADAC has been published 357 times since Dec 4, 2019.

FDA first approved this application on Sep 13, 2018. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.2137per EA
DEA Schedule CII

Strength

300; 7.5 mg/1; mg/1

NDC

13107021205

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207709

FDA Approved

9/13/2018

TE Code

AA

On Market Since

5/6/2015

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has been published 357 times since Dec 4, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.2137 per EA
All-time high$0.6564 (Jun 10, 2020)
All-time low$0.1542 (Jul 17, 2024)
52-week high$0.2137
52-week low$0.1719
Median price$0.2433
Average price$0.2904
Largest weekly change+89.2% (Apr 22, 2020)
Weeks tracked357
Tracking sinceDec 4, 2019

Price History

1W

0.0%

1M

+9.4%

3M

+12.2%

6M

+19.1%

1Y

+3.3%

3Y

-51.5%

5Y

-26.1%

All

-1.1%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.2137 per EA (NDC 13107021205), effective Sep 30, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has held within roughly two percent of its current level. It has been tracked across 357 weekly CMS publications since Dec 4, 2019.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

Since Dec 4, 2019, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has ranged from a low of $0.1542 (Jul 17, 2024) to a high of $0.6564 (Jun 10, 2020), with a median of $0.2433 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, is $0.1741 per EA — about 19% below HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET (NDC 13107021205) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.